Skip to main content

CAPITAL FUND MANAGEMENT S.A.

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1323645 PARIS, I0

Position in APLS

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
68,112
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
19,100
PutValue
$0
PutShares
14,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CAPITAL FUND MANAGEMENT S.A. holds $326,278,392 across 42 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 68,112
2025-09-30 14,300
2025-09-30 19,100
2025-06-30 14,500
2025-06-30 21,900
2024-12-31 121,433
2024-09-30 243,234
2024-06-30 201,487
2023-12-31 25,000
2023-12-31 50,400
2023-09-30 90,400
2023-09-30 57,700
2023-06-30 10,100
2022-12-31 12,884
2022-03-31 10,620